how does the body produce glp 1 GLP-1 and Microbiome Repair for Long-Term Metabolism GLP-1 and Microbiome Repair for

Advanced Metabolic Signaling Research

How many people take GLP-1 medications

No direct causal link has been established between GLP-1R use and increased aspiration risk

As a coach, you may be wondering: Where do I fit in

Tackling multiple diseases with a single prescription, making GLP-1s a disruptor in todays medical landscape

("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced that new clinical data from the company's VK2735 obesity program were highlighted in a poster presentation at ObesityWeek 2025, the annual meeting of The Obesity Society